Garman-Klass Volatility Calculation – Volatility Analysis in Python

Follow us on LinkedIn

In the previous post, we introduced the Parkinson volatility estimator that takes into account the high and low prices of a stock. In this follow-up post, we present the Garman-Klass volatility estimator that uses not only the high and low but also the opening and closing prices.

Garman-Klass (GK) volatility estimator consists of using the returns of the open, high, low, and closing prices in its calculation. It is calculated as follow,

Volatility Analysis in Python Garman-Klass

where hi denotes the daily high price, li is the daily low price, ci is the daily closing price and oi is the daily opening price.

We implemented the above equation in Python. We downloaded SPY data from Yahoo finance and calculated GK historical volatility using the Python program. The picture below shows the GK historical volatility of SPY from March 2015 to March 2020.

Garman-Klass Volatility in Python

The GK volatility estimator has the following characteristics [1]

Advantages

  • It is up to eight times more efficient than the close-to-close estimator
  • It makes the best use of the commonly available price information

Disadvantages

  • It is even more biased than the Parkinson estimator

Also check out Historical Volatility Online Calculator.

References

[1] E. Sinclair, Volatility Trading, John Wiley & Sons, 2008

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSThe South Park stock market jinx could be coming for high-flying weight-loss stocks
The South Park stock market jinx could be coming for high-flying weight-loss stocks

An analysis found that a stock underperformed the S&P 500 by a median of 7% in the year after being featured in the animated comedy.

Stay up-to-date with the latest news - click here
LATEST NEWSEarnings call: CollPlant reports Q1 2024 results and corporate updates
Earnings call: CollPlant reports Q1 2024 results and corporate updates
Stay up-to-date with the latest news - click here
LATEST NEWSEarnings call: Covalon turns profitable with strong Q2 performance
Earnings call: Covalon turns profitable with strong Q2 performance
Stay up-to-date with the latest news - click here
LATEST NEWSUS health insurer shares fall after UnitedHealth flags Medicaid enrollment issues
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues
Stay up-to-date with the latest news - click here
LATEST NEWSBESREMi ® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
BESREMi ® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
Stay up-to-date with the latest news - click here

Leave a Reply